Delivery Order SPE2DB22D2108-SPE2DB25FU4FK
Award Date
4/28/25
Potential Completion Date
4/29/25
Potential Value
$29K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,879.70 firm fixed-price delivery order is for the supply of Mounjaro 7.5 mg/0.5 ml pens, a medication used to treat diabetes. The contract has an ultimate completion date of April 22, 2025. This award is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $13,308.65, is for the provision of the diabetes medication Mounjaro (7.5 mg/0.5 ml pen) to support military and government healthcare programs. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 24, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,758.60, is for the supply of the diabetes medication Mounjaro 7.5 mg/0.5 ml pen. The delivery order has an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global...
This federal contract award, valued at $25,083.05, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB25FU4CM) for the supply of Mounjaro 10 mg/0.5 ml pens, a medication used to treat diabetes. The contract is not set aside and has an ultimate completion date of April 17, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,156.88 firm fixed-price delivery order is for the drug Mounjaro 12.5 mg/0.5 ml pen, a medication used for the treatment of diabetes. The contract has an ultimate completion date of June 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,897.62, is for the supply of Mounjaro 7.5 mg/0.5 ml pens, a diabetes medication. The contract has an ultimate completion date of April 28, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,967,847 units of the diabetes medication Mounjaro 15 mg/0.5 ml pen. The total ceiling value of the contract is $10,936.86 with a performance period ending on April 21, 2025. This award is not set-aside and represents open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,578.00 firm fixed-price delivery order is for the supply of the diabetes medication Mounjaro (5 mg/0.5 ml pen, 0.5 ml) with an ultimate completion date of October 31, 2024. The contract is not designated as a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,530.64 contract is for the supply of Mounjaro 5 mg/0.5 ml pens, a diabetes medication. The order has an ultimate completion date of April 16, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive...
This federal contract award, with ID SPE2DB22D1002|SPE2DB25FKUE5, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,963.80 firm-fixed-price delivery order is for the supply of Mounjaro 7.5 mg/0.5 ml pens, a diabetes medication. The contract has a completion date of November 14, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...